N3 alkylated benzimidazole derivatives as MEK inhibitors

Details N3 alkylated benzimidazole derivatives as MEK inhibitors N3 alkylated benzimidazole derivatives as MEK inhibitors

2007-06-14

2010-11-30

Stockton, Laura L. (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S394000

Reexamination Certificate

active

07842816

ABSTRACT:
Disclosed are amino acid prodrugs of compounds of the formula Iand pharmaceutically acceptable salts thereof, wherein W, R1, R2, R7, R8, R9and R10are as defined in the specification. Such compounds are MEK inhibitors and useful in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals. Also disclosed is a method of using such compounds in the treatment of hyperproliferative disease in mammals, and pharmaceutical compositions containing such compounds.

REFERENCES:
patent: 5525625 (1996-06-01), Bridges et al.
patent: 5750545 (1998-05-01), Akahoshi et al.
patent: 6310060 (2001-10-01), Barrett et al.
patent: 6440966 (2002-08-01), Barrett et al.
patent: 6455582 (2002-09-01), Tecle
patent: 6469004 (2002-10-01), Barrett et al.
patent: 6506798 (2003-01-01), Barrett et al.
patent: 6545030 (2003-04-01), Barrett et al.
patent: 6696440 (2004-02-01), Bridges et al.
patent: 6750217 (2004-06-01), Barrett et al.
patent: 6821963 (2004-11-01), Barrett et al.
patent: 6960614 (2005-11-01), Barrett et al.
patent: 7001905 (2006-02-01), Biwersi et al.
patent: 7030119 (2006-04-01), Barrett et al.
patent: 7067532 (2006-06-01), Boyle et al.
patent: 7169816 (2007-01-01), Barrett et al.
patent: 2004/0039208 (2004-02-01), Chen et al.
patent: 98/43960 (1998-10-01), None
patent: 00/40237 (2000-07-01), None
patent: 00/41505 (2000-07-01), None
patent: 00/68201 (2000-11-01), None
patent: 01/05391 (2001-01-01), None
patent: 01/05392 (2001-01-01), None
patent: 01/05393 (2001-01-01), None
Souillac, et al., Characterization of Delivery Systems, Differential Scanning Calorimetry, in Encyclopedia of Controlled Drug Delivery, 1999, John Wiley & Sons, pp. 212-227.
Vippagunta et al., Advanced Drug Delivery Reviews, 48 (2001), pp. 3-26.
Golub, T.R. et al., “Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring”, Science, vol. 286, Oct. 15, 1999, pp. 531-537.
Friis, G.J. et al., “Prodrugs of Phosphates and Phosphonates: Novel Lipophilic a-Acyloxyalkyl Ester Derivatives of Phosphate- or Phosphonate Containing Drugs Masking the Negative Charges of These Groups”, European Journal of Pharmaceutical Sciences, vol. 4, (1996), pp. 49-59.

Affiliated with

Also associated with

Rating

N3 alkylated benzimidazole derivatives as MEK inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N3 alkylated benzimidazole derivatives as MEK inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N3 alkylated benzimidazole derivatives as MEK inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4252579